Insights

April 30, 2024

COVID-19 and its impact on high-risk groups

There have been a few COVID-19 updates in the news in the last month. It is important for people who are at high-risk of serious illness to be aware of these changes, including adults aged 65 years and older, pregnant people, children aged 5 years and under, and people with weakened immune systems due to medical conditions or immunosuppressive treatments. Read now

April 17, 2024

Optimizing Cancer Care and Costs

Natalya Gertsik, PhD, Vice President of ClearCancer Solution, and Tommy Axford, FSA, MAAA, SVP Strategic Partnerships, join Springbuk’s “Healthcare Rocks” podcast to discuss PHM’s cutting-edge solution, ClearCancer, and how employers and advisors are adopting data-driven strategies to address the challenges of high-cost cancer treatments. Listen now

April 15, 2024

How to talk to kids about cancer

At PHM, we advocate for a family-centered approach to care. Alongside our highly skilled advanced practice clinicians, PhD-led research scientists, and expert coordinators, we offer the support of Certified Child Life Specialists in-house. These specialists assist our clients in having difficult conversations with their children following a new cancer diagnosis and prepare them for what emotional or behavioral reactions they can expect. Read now

March 07, 2024

Gene editing-based therapies could revolutionize how genetic diseases are treated

Patients with the debilitating, inherited blood disorders sickle cell anemia and beta-thalassemia recently received news of a life-changing treatment. The FDA approved Casgevy, a groundbreaking therapy that uses a gene editing tool called CRISPR (pronounced ‘crisper’) to treat these disorders. This is the first ever approval for this innovative type of treatment, which can change the DNA code in a patient’s cells to target the underlying cause of a disease. Read now

March 07, 2024

What to know about measles outbreak in the U.S.

Measles cases are on the rise globally, despite the availability of a safe and effective vaccine that prevents the infection. In the U.K., where over 400 cases have been detected since October of 2023,1 the alarming surge has been deemed a “national incident.” As a result, the U.S. Centers for Disease Control (CDC) issued a warning for physicians to be on alert for measles cases. Read now

March 07, 2024

Raising awareness of a rare type of stroke

The American Heart Association (AHA) recently released new analysis and recommendations for the diagnosis and treatment of a…

Read now

March 07, 2024

Early cancer detection is paramount in the relentless battle against cancer

Recent findings from the American Cancer Society’s latest 2024 Cancer Statistics report paint a complex picture: while overall…

Read now

March 07, 2024

PHM’s Evidence-Based Approach Reduces Treatment Uncertainty for Our Patient with Breast Cancer

Many cancer patients are faced with deep, personal decisions about what treatment path will be right for them.…

Read now

February 15, 2024

Securing top-quality medical care for family members with Leslie Michelson

Leslie Michelson, Chairman and Co-Founder of PHM, has over five decades of experience navigating our fragmented healthcare systems for individuals, family offices, and employers. In the Family Office Exchange podcast with FOX CEO Peter Moustakerski, Leslie ​challenges the misconception that access and wealth guarantee the right healthcare. He shares strategies and tools from his best-selling book, "The Patient’s Playbook." Listen now

February 14, 2024

The future of precision cancer therapy might be to try everything

This article, published by Nature, references PHM’s case study, published in Frontiers in Oncology, in partnership with SEngine…

Read now

February 12, 2024

Pancreatic Cancer Treatment Option Study Published

Pancreatic cancer is notoriously difficult to treat. At PHM we deploy comprehensive molecular profiling to identify potential treatment…

Read now